Global Pets Anti-infective Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pets Anti-infective Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Leptospirosis, staphylococcal infection, bacterial ear infection, actinomycosis, and nocardiosis are some of the most common forms of infections in pets. Moreover, pets are susceptible to bacterial diseases, such as plague, brucellosis, and Lyme disease. Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an organism infectious or by killing the infectious organism outright.This term encompasses antibiotics, antifungals etc.
Pets Anti-infective Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pets Anti-infective Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Dog and Cat are the major drivers for the industry.
In the China market, core pets anti-infective drugs manufacturers include Zoetis, Merck and Elanco etc. The Top 3 companies hold a share above 40%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pets Anti-infective Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Administration Method, Application and Regions Listed in the Report
Zoetis
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva Santé Animale
Vetoquinol
Nanjing Jindun Animal
Wuhan Chopperlvya
Bimeda Animal Health
Ouro Fino Saude
Norbrook
Segment by Administration Method
External Use
Internal Use
Injection
Dog
Cat
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pets Anti-infective Drugs market further
Chapter 1Product Definition, Product Administration Methods, Volume and Revenue analysis of Each Administration Method in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pets Anti-infective Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pets Anti-infective Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pets Anti-infective Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pets Anti-infective Drugs introduction, etc. Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pets Anti-infective Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Pets Anti-infective Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pets Anti-infective Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Dog and Cat are the major drivers for the industry.
In the China market, core pets anti-infective drugs manufacturers include Zoetis, Merck and Elanco etc. The Top 3 companies hold a share above 40%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pets Anti-infective Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Administration Method, Application and Regions Listed in the Report
By Company
Zoetis
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva Santé Animale
Vetoquinol
Nanjing Jindun Animal
Wuhan Chopperlvya
Bimeda Animal Health
Ouro Fino Saude
Norbrook
Segment by Administration Method
External Use
Internal Use
Injection
Segment by Application
Dog
Cat
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pets Anti-infective Drugs market further
Chapter 1Product Definition, Product Administration Methods, Volume and Revenue analysis of Each Administration Method in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pets Anti-infective Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pets Anti-infective Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pets Anti-infective Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pets Anti-infective Drugs introduction, etc. Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pets Anti-infective Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.